

Notes:
Volume 8
Journal of Gastrointestinal & Digestive System
ISSN: 2161-069X
Page 15
JOINT EVENT
Pediatric Gastro 2018
Digestive Diseases 2018
October 22-23, 2018
October 22-23, 2018 Berlin, Germany
3
rd
International Conference on
Digestive and Metabolic Diseases
Pediatric Gastroenterology Hepatology & Nutrition
13
th
International Conference on
&
Ahmed Shara, J Gastrointest Dig Syst 2018, Volume 8
DOI: 10.4172/2161-069X-C7-082
The role of vitamin D levels in early onset sepsis development in term neonates
Ahmed Shara
Tanta university, Egypt
Introduction
: Newborns are more susceptible to infections as both innate and adaptive immune systems are not entirely
developed. Vitamin D is a fat-soluble steroid hormone that contributes to the maintenance of normal calcium homeostasis and
skeletal mineralization. Vitamin D also has immunomodulatory effects on immune function. It was suggested that it might
have a role in the optimal functioning of the innate immune system by inducing antimicrobial peptides in epithelial cells,
neutrophils and macrophages.
Aim of the Work:
The aim of this study was to determine the role of vitamin D levels as diagnostic predictor of early onset
sepsis development in term neonates.
Patients and Methods:
Fourty term infants with clinical and laboratory findings of EOS (study group) and 40 healthy infants
with no signs of clinical/laboratory infection (control group) were enrolled. Blood was drawn at the time of admission during
the first 3 postnatal days of life in both groups for measurement of 25-hydroxyvitamin D (25-OHD) levels.
Result:
Neonatal 25-OHD levels (11.59 ± 4.66ng ml−1) in the study group were significantly lower than those of the control
group (27.35 ± 3.45ng ml−1, P<0.001). Severe vitamin D deficiency was significantly more common in the sepsis group.
Conclusion:
Lower neonatal 25-OHD levels are associated with EOS. These data suggest that adequate vitamin D
supplementation during pregnancy may be helpful to prevent EOS in term neonates.
Biography
Ahmed Shara has completed his PhD at the age of 25 years from Tanta University, Egypt and postdoctoral studies from Stanford University School of Medicine.
He is the director of a premier Bio-Soft service organization. He has published more than 25 papers in reputed journals and has been serving as an editorial board
member of repute. (Up to 100 words).
a_sharr3@hotmail.com